Blu Label Unlimited Group (BLU) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
26 Aug, 2026Executive summary
Achieved disciplined execution and simplification through the successful restructuring and listing of Cell C, reducing risk and improving earnings visibility while retaining strategic optionality.
Delivered normalized revenue of ZAR 9.4 billion, EBITDA of ZAR 923 million, and net profit after tax of ZAR 677 million for FY2026.
Core headline earnings were ZAR 681 million (75.33 cents per share), with a total dividend of 53.56 cents per share.
Resumed dividend distributions and initiated a share repurchase program, reflecting confidence in cash generation and capital allocation flexibility.
BluAdvance, BluNova, Cigicell, and BluEnergy platforms scaled and contributed to growth, margin enhancement, and new energy sector opportunities.
Financial highlights
Normalized revenue reached ZAR 9.4 billion; gross income was ZAR 2.555 billion; EBITDA ZAR 923 million; net profit after tax ZAR 677 million.
Core headline earnings were ZAR 681 million, or 75.33 cents per share; total dividend for the year was 53.56 cents per share.
Effective gross revenue (imputed) grew 7% year-over-year to ZAR 99.9 billion.
Reported revenue was ZAR 13.05 billion, with significant non-recurring items from Cell C restructuring; headline earnings adjustments included a net loss of ZAR 5.6 billion.
Free cash flow conversion rate approximately 65%; cash conversion ratio about 82%.
Outlook and guidance
FY2027 priorities: cash generation, liquidity, disciplined execution, and margin protection, with a focus on commercial execution in energy and payments.
Expect meaningful earnings from new energy and municipal projects from June 2027 onwards, with annuity income potential of 3–10 years.
Dividend policy targets 30–50% payout of core headline earnings (excluding Cell C), with 50–70% of Cell C dividends also distributed.
Board attention now directed toward growing operating businesses post-Cell C restructuring.
Latest events from Blu Label Unlimited Group
- AGM approved key resolutions, addressed diversity, ESG, and Cell C governance, with most motions passed.BLU
AGM 2024 - Significant declines in earnings expected due to Cell C restructuring and listing impacts.BLU
Trading update - Earnings per share are expected to rise over 100%, but underlying earnings fell when excluding Cell C effects.BLU
Trading update - Earnings per share are expected to rise by over 20% for the year ended 31 May 2025.BLU
Trading update - Earnings per share to fall over 20%, impacted by Cell C restructuring and related losses.BLU
Trading update - Gross revenue up 16% to ZAR 89.3bn, but core HEPS down 34% amid challenging conditions.BLU
H2 2024 - Gross revenue up 8% to R47.4bn, margins improved, but EBITDA fell on higher finance costs.BLU
H1 2025 - Profit and margin growth accelerated, led by digital innovation and Cell C's operational turnaround.BLU
H2 2025 - Cell C restructuring and 11% revenue growth enabled dividend resumption and strong cash flow.BLU
H1 2026